Results 81 to 90 of about 107,932 (308)

Portal Hypertension and a Stiff Liver. [PDF]

, 2018
Portal hypertension (PH) is a common clinical syndrome leading to severe complications. In the western world, about 90% of cases of PH are due to liver cirrhosis, and thanks to the availability of ultrasound elastography methods, this diagnosis is ...
Felicia D'Alitto, Annalisa Berzigotti, Pabst, Thomas, Amina Scherz, Matteo Montani, Scherz, Amina, Thomas Pabst, Montani, Matteo, Berzigotti, Annalisa, von Tengg-Kobligk, Hendrik, Margini, Cristina, D'Alitto, Felicia, Cristina Margini, Hendrik Von Tengg-Kobligk   +13 more
core   +1 more source

CAQ Corner: Basic concepts of transplant immunology

, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

Pathophysiology of Portal Hypertension [PDF]

Clinics in Liver Disease, 1964
Portal hypertension is a major complication of liver disease that results from a variety of pathologic conditions that increase the resistance to the portal blood flow into the liver. As portal hypertension develops, the formation of collateral vessels and arterial vasodilation progresses, which results in increased blood flow to the portal circulation.
openaire   +2 more sources

Pathophysiology and therapeutic options for cirrhotic portal hypertension.

Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy.
Guixé-Muntet, Sergi, Gracia-Sancho, Jordi, Quesada-Vázquez, Sergio   +2 more
core   +1 more source

CAQ Corner: Immune‐mediated complications

, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study

BMC Gastroenterology
Purpose Hepatocellular carcinoma (HCC) has a poor prognosis, and alpha-fetoprotein (AFP) is widely used to evaluate HCC. However, the proportion of AFP-negative individuals cannot be disregarded.
Chengyu Liu, Zikang Li, Zhilei Zhang, Jinlong Li, Congxi Xu, Yuming Jia, Chong Zhang, Wuhan Yang, Wenchuan Wang, Xiaojuan Wang, Kuopeng Liang, Li Peng, Jitao Wang   +12 more
doaj   +1 more source

Portal hypertension is associated with modulation of regulatory T cells

European Journal of Inflammation, 2016
Background: Portal hypertension is a complication of liver cirrhosis. The portal vein drains the spleen and the intestines, which are both rich in inflammatory mediators.
Tomer Adar, Yair Edden, Shimon Shteingart, Ami Ben Ya’acov, Mahmud Mahamid, Ellen Broide, Shimrit Shmorak, Ariella Bar-Gil Shitrit, Constantin Reinus, Eran Goldin   +9 more
doaj   +1 more source

Burden of pulmonary hypertension in patients with portal hypertension in the United States: a retrospective database study

Pulmonary Circulation, 2020
Patients with portal hypertension may develop pulmonary hypertension. The economic implications of these comorbidities have not been systematically assessed. We compared healthcare resource utilization and costs in the United States between patients with
Sandeep Sahay, Yuen Tsang, Megan Flynn, Peter Agron, Robert Dufour   +4 more
doaj   +1 more source

Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation [PDF]

, 2000
We tested the hypothesis that excessive portal venous supply of long-chain fatty acids to the liver contributes to the development of insulin resistance via activation of the hypothalamus-pituitary-adrenal axis (HPA axis) and sympathetic system.
Scheurink, AJW, Strubbe, JH, Keizer, Klaasjan,, Kuipers, Folkert,, Kuipers, F, Scheurink, Anton J.W.,, Benthem, L, Kuipers, F; id_orcid, Keizer, Klaas-Jan, Wiegman, Coen H.,, Strubbe, Jan H.,, Boer, Sietse F. de,, Steffens, Anton B.,, Steffens, AB, De Boer, SF, Benthem, Lambertus,, Wiegman, CH   +16 more
core  

Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension

, 2009
BACKGROUND/AIMS: Angiogenesis is a pathological hallmark of portal hypertension. Although VEGF is considered to be the most important proangiogenic factor in neoangiogenesis, this process requires the coordinated action of a variety of factors ...
Berzigotti, Annalisa, de Gottardi, Andrea, Tiani, Carolina, Bosch, Jaime, Fernandez, Mercedes, Garcia-Pras, Ester, Mejias, Marc   +6 more
core   +1 more source